The India-UK FTA is poised to bolster pharmaceutical and medical device supply chains, enhancing access to affordable medicines and fostering collaboration in bulk drugs and joint research. The agreement is expected to boost India’s generic drug exports to the UK, currently valued at $1 billion. The medical devices industry anticipates accelerated bilateral trade, emphasizing the need for streamlined regulatory approvals and stricter Rules of Origin checks. Post navigation Duty cuts on UK goods may aid firms more than buyers Deal sealed, but Scotch to stay pricey till 2035
